| scholarly article | Q13442814 |
| P356 | DOI | 10.1161/01.ATV.14.5.707 |
| P698 | PubMed publication ID | 8172849 |
| P2093 | author name string | J L Breslow | |
| E A Brinton | |||
| S Eisenberg | |||
| P433 | issue | 5 | |
| P921 | main subject | lipoprotein | Q28350 |
| triglyceride | Q186319 | ||
| preproinsulin | Q7240673 | ||
| P304 | page(s) | 707-720 | |
| P577 | publication date | 1994-05-01 | |
| P1433 | published in | Arteriosclerosis and thrombosis : a journal of vascular biology | Q27709770 |
| P1476 | title | Human HDL cholesterol levels are determined by apoA-I fractional catabolic rate, which correlates inversely with estimates of HDL particle size. Effects of gender, hepatic and lipoprotein lipases, triglyceride and insulin levels, and body fat distribution | |
| P478 | volume | 14 |
| Q37645650 | 2H2O-based high-density lipoprotein turnover method for the assessment of dynamic high-density lipoprotein function in mice |
| Q36892261 | A comparison of the theoretical relationship between HDL size and the ratio of HDL cholesterol to apolipoprotein A-I with experimental results from the Women's Health Study |
| Q28344150 | ABCA1 overexpression leads to hyperalphalipoproteinemia and increased biliary cholesterol excretion in transgenic mice |
| Q51564959 | Abnormal capacity to induce cholesterol efflux and a new LpA-I pre-beta particle in type 2 diabetic patients. |
| Q37292958 | Admixture mapping of quantitative trait loci for blood lipids in African-Americans |
| Q28540807 | An in-silico model of lipoprotein metabolism and kinetics for the evaluation of targets and biomarkers in the reverse cholesterol transport pathway |
| Q34740994 | Apolipoprotein A-II, HDL metabolism and atherosclerosis |
| Q73835678 | Apolipoprotein-mediated cellular cholesterol/phospholipid efflux and plasma high density lipoprotein level in mice |
| Q34284245 | Arginine-directed glycation and decreased HDL plasma concentration and functionality |
| Q51590377 | Changes of lipolytic enzymes cluster with insulin resistance syndrome. Botnia Study Group. |
| Q41625190 | Characteristics of lipid metabolism including serum apolipoprotein M levels in patients with primary nephrotic syndrome |
| Q37013499 | Cholesteryl Ester Transfer Protein Inhibition With Anacetrapib Decreases Fractional Clearance Rates of High-Density Lipoprotein Apolipoprotein A-I and Plasma Cholesteryl Ester Transfer Protein |
| Q37703935 | Cystatin C, CRP, log TG/HDLc and metabolic syndrome are associated with microalbuminuria in hypertension |
| Q33867662 | Dalcetrapib and anacetrapib differently impact HDL structure and function in rabbits and monkeys |
| Q37174921 | Defective HDL particle uptake in ob/ob hepatocytes causes decreased recycling, degradation, and selective lipid uptake |
| Q56971959 | Dietary fat elevates hepatic apoA-I production by increasing the fraction of apolipoprotein A-I mRNA in the translating pool |
| Q37311118 | Dose-dependent regulation of high-density lipoprotein metabolism with rosuvastatin in the metabolic syndrome |
| Q28586230 | Dramatically decreased high density lipoprotein cholesterol, increased remnant clearance, and insulin hypersensitivity in apolipoprotein A-II knockout mice suggest a complex role for apolipoprotein A-II in atherosclerosis susceptibility |
| Q77718606 | Dyslipoproteinaemia and hyperoxidative stress in the pathogenesis of endothelial dysfunction in non-insulin dependent diabetes mellitus: an hypothesis |
| Q37305534 | Effect of body mass index on apolipoprotein A-I kinetics in middle-aged men and postmenopausal women |
| Q36975580 | Effect of obesity on the plasma lipoprotein subclass profile in normoglycemic and normolipidemic men and women |
| Q35590298 | Effects of cholesteryl ester transfer protein inhibition on high-density lipoprotein subspecies, apolipoprotein A-I metabolism, and fecal sterol excretion. |
| Q74100687 | Effects of gender, hepatic lipase gene polymorphism and type 2 diabetes mellitus on hepatic lipase activity in Chinese |
| Q37260358 | Effects of hyperlipidaemia on plasma apolipoprotein M levels in patients with type 2 diabetes mellitus: an independent case-control study |
| Q44655345 | Effects of treatment with Sandostatin®LAR®on small dense LDL and remnant‐like lipoproteins in patients with acromegaly |
| Q33993240 | Effects of weight loss, induced by gastric bypass surgery, on HDL remodeling in obese women |
| Q34830395 | Endothelial lipase: direct evidence for a role in HDL metabolism |
| Q43546756 | Enhanced fractional catabolic rate of apo A-I and apo A-II in heterozygous subjects for apo A-I(Zaragoza) (L144R). |
| Q24608464 | Evaluation and treatment of hypertriglyceridemia: an Endocrine Society clinical practice guideline |
| Q44625678 | Evidence of linkage of HDL level variation to APOC3 in two samples with different ascertainment |
| Q46549709 | Genome scan for quantitative trait loci influencing HDL levels: evidence for multilocus inheritance in familial combined hyperlipidemia |
| Q38293496 | HDL and lifestyle interventions |
| Q35120941 | HDL from apoA1 transgenic mice expressing the 4WF isoform is resistant to oxidative loss of function |
| Q77104486 | HDL kinetics, fish oils and diabetes |
| Q33746644 | HDL metabolism in hypertriglyceridemic states: an overview |
| Q43889901 | HDL particle size: a marker of the gender difference in the metabolic risk profile |
| Q34181607 | HDL-replacement therapy: mechanism of action, types of agents and potential clinical indications |
| Q33817228 | High density lipoprotein oxidation: in vitro susceptibility and potential in vivo consequences |
| Q46564730 | High-density lipoprotein apolipoprotein A-I kinetics in obesity |
| Q39442094 | High-density lipoprotein subpopulation profiles in lipoprotein lipase and hepatic lipase deficiency. |
| Q35738372 | How do elevated triglycerides and low HDL-cholesterol affect inflammation and atherothrombosis? |
| Q37354180 | Hyperalphalipoproteinemia in human lecithin cholesterol acyltransferase transgenic rabbits. In vivo apolipoprotein A-I catabolism is delayed in a gene dose-dependent manner |
| Q73110385 | Hypolipidemic effect of NK-104, a potent HMG-CoA reductase inhibitor, in guinea pigs |
| Q77647860 | Increased intra-abdominal fat may lower HDL levels by increasing the fractional catabolic rate of Lp A-I in postmenopausal women |
| Q37378380 | Increased sphingomyelin content of plasma lipoproteins in apolipoprotein E knockout mice reflects combined production and catabolic defects and enhances reactivity with mammalian sphingomyelinase |
| Q37701553 | Increasing high-density lipoprotein as a therapeutic target in atherothrombotic disease |
| Q54036275 | Inefficiency of insulin therapy to correct apolipoprotein A-I metabolic abnormalities in non-insulin-dependent diabetes mellitus. |
| Q36300136 | Influence of dietary carbohydrate and fat on LDL and HDL particle distributions |
| Q37801630 | Insulin Resistance in Obesity as the Underlying Cause for the Metabolic Syndrome |
| Q49112760 | Lecithin:cholesterol acyltransferase overexpression generates hyperalpha-lipoproteinemia and a nonatherogenic lipoprotein pattern in transgenic rabbits |
| Q47788413 | Lipid-free apolipoprotein (apo) A-I is converted into alpha-migrating high density lipoproteins by lipoprotein-depleted plasma of normolipidemic donors and apo A-I-deficient patients but not of Tangier disease patients |
| Q35754362 | Lipoprotein kinetics in the metabolic syndrome: pathophysiological and therapeutic lessons from stable isotope studies |
| Q43561994 | LpAI in HDL subfractions: serum levels in men and women with coronary heart disease and changes under hypolipemic therapy. |
| Q44168323 | Mechanisms of HDL deficiency in mice overexpressing human apoA-II. |
| Q35209850 | Mechanisms of HDL lowering in insulin resistant, hypertriglyceridemic states: the combined effect of HDL triglyceride enrichment and elevated hepatic lipase activity |
| Q36403156 | Novel Pathways of Apolipoprotein A-I Metabolism in High-Density Lipoprotein of Different Sizes in Humans |
| Q57452976 | Pathogenesis of Lipid Disorders in Insulin Resistance: a Brief Review |
| Q44516309 | Plasma turnover of HDL apoC-I, apoC-III, and apoE in humans: in vivo evidence for a link between HDL apoC-III and apoA-I metabolism |
| Q81522402 | Polymorphism in the cholesteryl ester transfer protein gene and the risk of early onset myocardial infarction among cigarette smokers |
| Q51586643 | Postprandial lipoprotein responses in hypertriglyceridemic subjects with and without cardiovascular disease |
| Q51580855 | Postprandial reduction in high-density lipoprotein cholesterol concentrations in postmenopausal women: improvement by 17beta-estradiol. |
| Q37353135 | Potent and selective PPAR-alpha agonist LY518674 upregulates both ApoA-I production and catabolism in human subjects with the metabolic syndrome |
| Q37683292 | Proteolysis of apolipoprotein A-I by secretory phospholipase A₂: a new link between inflammation and atherosclerosis |
| Q37666992 | Regulation of high-density lipoprotein by inflammatory cytokines: establishing links between immune dysfunction and cardiovascular disease |
| Q36372677 | Relation of gemfibrozil treatment and high-density lipoprotein subpopulation profile with cardiovascular events in the Veterans Affairs High-Density Lipoprotein Intervention Trial. |
| Q28214360 | Relation of the -514C/T polymorphism in the hepatic lipase gene to serum HDL and LDL cholesterol levels in postmenopausal women under hormone replacement therapy |
| Q33781024 | Relationships between serum lipid, lipoprotein, triglyceride-rich lipoprotein, and high-density lipoprotein particle concentrations in post-renal transplant patients. |
| Q35767590 | Severe hypertriglyceridemia, reduced high density lipoprotein, and neonatal death in lipoprotein lipase knockout mice. Mild hypertriglyceridemia with impaired very low density lipoprotein clearance in heterozygotes |
| Q74106132 | Taq1B CETP polymorphism, plasma CETP, lipoproteins, apolipoproteins and sex differences in a Jewish population sample characterized by low HDL-cholesterol |
| Q33746670 | Targeting HDL-mediated cellular cholesterol efflux for the treatment and prevention of atherosclerosis |
| Q38553529 | Targeting inflammation in metabolic syndrome. |
| Q51576654 | The insulin resistance syndrome and postprandial lipid intolerance in smokers. |
| Q34548582 | The mechanism of HDL lowering in hypertriglyceridemic, insulin-resistant states |
| Q57605958 | The relationship between apolipoprotein AI-containing lipoprotein fractions and environmental factors: the prospective epidemiological study of myocardial infarction (PRIME study) |
| Q36473656 | Thematic review series: patient-oriented research. What have we learned about HDL metabolism from kinetics studies in humans? |
| Q34294723 | Transcription factors as drug targets: opportunities for therapeutic selectivity. |
| Q33887783 | Treatment of Dyslipidemias to Prevent Cardiovascular Disease in Patients with Type 2 Diabetes |
| Q33849302 | Triglyceride enrichment of HDL enhances in vivo metabolic clearance of HDL apo A-I in healthy men. |
| Q35740688 | Type 2 diabetes affects hippocampus volume differentially in men and women. |
Warning: Trying to access array offset on value of type null in /home/httpd/vhosts/renenyffenegger.ch/opendata.renenyffenegger.ch/Wikimedia/Wikidata/entity/main.php on line 1120 Warning: Trying to access array offset on value of type null in /home/httpd/vhosts/renenyffenegger.ch/opendata.renenyffenegger.ch/Wikimedia/Wikidata/entity/main.php on line 1120
Search more.